|
Volumn 51, Issue 14, 2001, Pages 1528-1533
|
Autoimmune diseases: Mechanisms and therapeutic prospects;Mécanismes de l'auto-immunité et implications thérapeutiques
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
ETANERCEPT;
INFLIXIMAB;
INSULIN;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
LEFLUNOMIDE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TUMOR NECROSIS FACTOR ALPHA;
ANKYLOSING SPONDYLITIS;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE ACTIVATION;
CYTOKINE PRODUCTION;
DISEASE COURSE;
GENETIC PREDISPOSITION;
HASHIMOTO DISEASE;
HUMAN;
IMMUNITY;
IMMUNOLOGICAL TOLERANCE;
IMMUNOTHERAPY;
INFECTION;
INSULIN DEPENDENT DIABETES MELLITUS;
REVIEW;
SYSTEMIC LUPUS ERYTHEMATOSUS;
T LYMPHOCYTE ACTIVATION;
THYROID CRISIS;
AUTOANTIBODIES;
AUTOANTIGENS;
AUTOIMMUNE DISEASES;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
HUMANS;
INTERFERON TYPE II;
T-LYMPHOCYTES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035883735
PISSN: 00352640
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (21)
|